| Financial Year |
March 31 2023 |
| Monetary Funds |
348,095,993.14 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
23,746,911.51 |
| Accounts Receivable |
368,140,156.62 |
| Advances to Suppliers |
12,511,922.87 |
| Other Receivables |
58,383,934.76 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,090,175,263.42 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
51,062,882.89 |
| Total Current Assets |
2,952,117,065.21 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
58,182,086.90 |
| Investment Properties |
371,059,873.30 |
| Fixed Assetes |
359,287,572.07 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
32,251,415.40 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
129,941,028.99 |
| Deferred Income Tax Assets |
92,849,263.82 |
| Other Non-Current Assets |
11,747,499.02 |
| Sub-Total of Non-Current Assets |
1,147,908,148.02 |
| Total Assets |
4,100,025,213.23 |
| Short-Term Loans |
290,224,736.11 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,000,600.00 |
| Accounts Payable |
124,137,573.10 |
| Accounts Received In Advance |
10,651,706.80 |
| Employee Compensation Payable |
95,190,163.89 |
| Taxes Payable |
64,283,879.12 |
| Interest Payable |
-- |
| Dividend Payable |
3,423,458.72 |
| Other payables |
142,432,724.66 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
60,494,208.97 |
| Other Current Liabilities |
1,902,319.63 |
| Sub-Total of Current Liabilities |
806,274,632.99 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
5,323,108.41 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
40,954,244.33 |
| Total Liabilities |
847,228,877.32 |
| Paid-In Capital(Or Share Stock) |
417,627,960.00 |
| Capital Surplus |
1,002,934,806.10 |
| Surplus Reserve |
275,010,401.50 |
| LESS:Treasury Stock |
31,260,789.45 |
| Undistributed Profits |
1,582,896,127.76 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,252,796,335.91 |
| Owner's Equity（Stockholder's Equity） |
3,252,796,335.91 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,100,025,213.23 |
